0001384101-21-000074.txt : 20210505
0001384101-21-000074.hdr.sgml : 20210505
20210505164100
ACCESSION NUMBER: 0001384101-21-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210503
FILED AS OF DATE: 20210505
DATE AS OF CHANGE: 20210505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EASTHAM KARIN
CENTRAL INDEX KEY: 0001231845
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 21894052
MAIL ADDRESS:
STREET 1: C/O BURNHAM INSTITUTE FOR MEDICAL RESEAR
STREET 2: 10901 N. TORREY PINES ROAD
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
wf-form4_162024723253740.xml
FORM 4
X0306
4
2021-05-03
0
0001384101
VERACYTE, INC.
VCYT
0001231845
EASTHAM KARIN
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2021-05-03
4
S
0
3527
48.0135
D
9700
I
By IRA
Common Stock
2021-05-03
4
S
0
650
48.9985
D
9050
I
By IRA
Common Stock
2021-05-03
4
S
0
250
50.028
D
8800
I
By IRA
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 25, 2020.
Represents weighted average sales price. Sale prices for the transactions range from $47.54 to $48.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $48.55 to $49.22. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $49.92 to $50.10. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
/s/ Keith S. Kennedy, as Attorney-in-fact
2021-05-05